Last reviewed · How we verify
NCT05889364
AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation
trial testing AI-based x-ray analysis and triage ("normal/tuberculosis suspected") in Tuberculosis, Pulmonary in 308 participants. Status unknown.
15 March 2018
Quick facts
| Lead sponsor | Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 308 |
| Start date | 1 February 2018 |
| Primary completion | 15 March 2018 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- AI-based x-ray analysis and triage ("normal/tuberculosis suspected")
Conditions studied
- Tuberculosis, Pulmonary — all drugs for Tuberculosis, Pulmonary →
Sponsor
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Who can join
Adults 18 to 80, any sex, with Tuberculosis, Pulmonary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Testing of AI solutions to assess diagnostic accuracy for tuberculosis detection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05889364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tuberculosis, Pulmonary
Currently open trials in the same condition.
- NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
- NCT07271225 — Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting · NA · recruiting
- NCT06845618 — Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment · recruiting
- NCT06253715 — Shortened Regimen for Drug-susceptible TB in Children · Phase 3 · recruiting
- NCT06057519 — Pragmatic Optimized Rifampicin Trial · Phase 3 · recruiting
Other Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department trials
Trials by the same sponsor.
- NCT07057830 — Generative AI Radiologist's Workstation · not yet recruiting
- NCT06501599 — AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes · recruiting
- NCT05994716 — Telemonitoring for IBD Goodness Examination in Russia · NA · unknown
- NCT04862026 — Telemonitoring of Patients With Acute Coronary Syndrome · suspended
- NCT04944472 — Possibilities of Perceiving Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From E · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05889364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
- Last refreshed: 5 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing